Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes

NewPred, a semiautomated procedure to evaluate alternate binding modes and assist three dimensional quantitative structure-activity relationship (3D-QSAR) studies in predictive power evaluation is exemplified with a series of 30 human immunodeficiency virus 1 protease (HIV PR) inhibitors. Five compa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 1994-07, Vol.37 (14), p.2206-2215
Hauptverfasser: Oprea, Tudor I, Waller, Chris L, Marshall, Garland R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2215
container_issue 14
container_start_page 2206
container_title Journal of medicinal chemistry
container_volume 37
creator Oprea, Tudor I
Waller, Chris L
Marshall, Garland R
description NewPred, a semiautomated procedure to evaluate alternate binding modes and assist three dimensional quantitative structure-activity relationship (3D-QSAR) studies in predictive power evaluation is exemplified with a series of 30 human immunodeficiency virus 1 protease (HIV PR) inhibitors. Five comparative molecular field analysis (CoMFA) models (Waller, C. L.; et al. J. Med. Chem. 1993, 36, 4152-4160) based on 59 HIV-PR inhibitors were tested. The test set included 18 compounds (set A) having a different transition state isostere (TSI), hydroxyethylurea (Getman, D. P.; et al. J. Med. Chem. 1993, 36, 288-291), to investigate the binding mode in P1' and P2'. Twelve dihyroxyethylenes (set B) (Thaisrivongs, S.; et al. J. Med. Chem. 1993, 36, 941-952) were used to investigate binding in P2 and P3 as well as in P2' and P3'. Six other compounds with known or inferred binding structure (set C) were part of the test set, but not investigated with NewPred. Each compound was aligned in accordance to predefined alignment rules for the training set prior to the inclusion in the test set (except for set C). Using NewPred, geometrically different conformers for each compound were generated and individually relaxed in the HIV-PR binding site. Energy comparisons allowed selection of lowest energy structures to be included in the test set. Only in vacuo minimized conformers derived from low-energy complexes were used to determine the predictive power of the five models (predictive r2 varied from 0.1 to 0.7 when two chemical and statistical outliers were excluded). Our models correctly predict the poor inhibitor activity of 1(S)-amino-2(R)-hydroxyindan-containing peptides (set B), which is explained and interpreted from a 3D-QSAR perspective. The use of a new, flexibility-based, semiautomated method to explore alternate binding models for 3D-QSAR models is demonstrated.
doi_str_mv 10.1021/jm00040a013
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76593483</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76593483</sourcerecordid><originalsourceid>FETCH-LOGICAL-a300t-1fc4c24c283b06760404f662a7bb30ccebcffdf5e14f5e6ecf4ec78cf38a9dcb3</originalsourceid><addsrcrecordid>eNqFkctrFEEQxgdR4ho9eRb65AOZtR_z2mMMaiIBF1wvXpqenmq31pnuTT9i9r_zT7M3uwQPglB0QX8_6qPqK4rnjM4Z5ezdZqKUVlRRJh4UM1ZzWlYdrR4WM0o5L3nDxePiSQibjAnGxUlx0lFRV7ybFb9Xaw9QDjiBDeisGsl1UjZiVBFvgITok47JQ6l0_sC4Ix7GrDkb1rglzpB1mpQlOE3JugEMagSrd-QGfQrk9eUbsvUuggpA0K6xx-h8mBM-J0sPA-o7m637BZ6kgPYHGXHCCAOB2-3o_J3V3kaNEbxVEUiPdtiDU7YLT4tHRo0Bnh37afHt44fV-UV59eXT5fnZVakEpbFkRlea5-pET5u2yfeqTNNw1fa9oFpDr40ZTA2syk8D2lSg204b0anFoHtxWrw8zM3bXCcIUU4YNIyjsuBSkG1TL0TVif-CrGnbBadNBt8eQO1dCB6M3HqclN9JRuU-WPlXsJl-cRyb-gmGe_aYZNbLg44hwu29rPxP2bSireVq-VW-p995ffF5KVeZf3XglQ5y41I-7Rj-6fwHCt3AWg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16779206</pqid></control><display><type>article</type><title>Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes</title><source>MEDLINE</source><source>ACS Publications</source><creator>Oprea, Tudor I ; Waller, Chris L ; Marshall, Garland R</creator><creatorcontrib>Oprea, Tudor I ; Waller, Chris L ; Marshall, Garland R</creatorcontrib><description>NewPred, a semiautomated procedure to evaluate alternate binding modes and assist three dimensional quantitative structure-activity relationship (3D-QSAR) studies in predictive power evaluation is exemplified with a series of 30 human immunodeficiency virus 1 protease (HIV PR) inhibitors. Five comparative molecular field analysis (CoMFA) models (Waller, C. L.; et al. J. Med. Chem. 1993, 36, 4152-4160) based on 59 HIV-PR inhibitors were tested. The test set included 18 compounds (set A) having a different transition state isostere (TSI), hydroxyethylurea (Getman, D. P.; et al. J. Med. Chem. 1993, 36, 288-291), to investigate the binding mode in P1' and P2'. Twelve dihyroxyethylenes (set B) (Thaisrivongs, S.; et al. J. Med. Chem. 1993, 36, 941-952) were used to investigate binding in P2 and P3 as well as in P2' and P3'. Six other compounds with known or inferred binding structure (set C) were part of the test set, but not investigated with NewPred. Each compound was aligned in accordance to predefined alignment rules for the training set prior to the inclusion in the test set (except for set C). Using NewPred, geometrically different conformers for each compound were generated and individually relaxed in the HIV-PR binding site. Energy comparisons allowed selection of lowest energy structures to be included in the test set. Only in vacuo minimized conformers derived from low-energy complexes were used to determine the predictive power of the five models (predictive r2 varied from 0.1 to 0.7 when two chemical and statistical outliers were excluded). Our models correctly predict the poor inhibitor activity of 1(S)-amino-2(R)-hydroxyindan-containing peptides (set B), which is explained and interpreted from a 3D-QSAR perspective. The use of a new, flexibility-based, semiautomated method to explore alternate binding models for 3D-QSAR models is demonstrated.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm00040a013</identifier><identifier>PMID: 8035428</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>AIDS/HIV ; Amino Acid Sequence ; Binding Sites ; HIV Protease ; HIV Protease Inhibitors - chemistry ; HIV Protease Inhibitors - pharmacology ; human immunodeficiency virus ; Models, Molecular ; Molecular Conformation ; Molecular Sequence Data ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 1994-07, Vol.37 (14), p.2206-2215</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a300t-1fc4c24c283b06760404f662a7bb30ccebcffdf5e14f5e6ecf4ec78cf38a9dcb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm00040a013$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm00040a013$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8035428$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oprea, Tudor I</creatorcontrib><creatorcontrib>Waller, Chris L</creatorcontrib><creatorcontrib>Marshall, Garland R</creatorcontrib><title>Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>NewPred, a semiautomated procedure to evaluate alternate binding modes and assist three dimensional quantitative structure-activity relationship (3D-QSAR) studies in predictive power evaluation is exemplified with a series of 30 human immunodeficiency virus 1 protease (HIV PR) inhibitors. Five comparative molecular field analysis (CoMFA) models (Waller, C. L.; et al. J. Med. Chem. 1993, 36, 4152-4160) based on 59 HIV-PR inhibitors were tested. The test set included 18 compounds (set A) having a different transition state isostere (TSI), hydroxyethylurea (Getman, D. P.; et al. J. Med. Chem. 1993, 36, 288-291), to investigate the binding mode in P1' and P2'. Twelve dihyroxyethylenes (set B) (Thaisrivongs, S.; et al. J. Med. Chem. 1993, 36, 941-952) were used to investigate binding in P2 and P3 as well as in P2' and P3'. Six other compounds with known or inferred binding structure (set C) were part of the test set, but not investigated with NewPred. Each compound was aligned in accordance to predefined alignment rules for the training set prior to the inclusion in the test set (except for set C). Using NewPred, geometrically different conformers for each compound were generated and individually relaxed in the HIV-PR binding site. Energy comparisons allowed selection of lowest energy structures to be included in the test set. Only in vacuo minimized conformers derived from low-energy complexes were used to determine the predictive power of the five models (predictive r2 varied from 0.1 to 0.7 when two chemical and statistical outliers were excluded). Our models correctly predict the poor inhibitor activity of 1(S)-amino-2(R)-hydroxyindan-containing peptides (set B), which is explained and interpreted from a 3D-QSAR perspective. The use of a new, flexibility-based, semiautomated method to explore alternate binding models for 3D-QSAR models is demonstrated.</description><subject>AIDS/HIV</subject><subject>Amino Acid Sequence</subject><subject>Binding Sites</subject><subject>HIV Protease</subject><subject>HIV Protease Inhibitors - chemistry</subject><subject>HIV Protease Inhibitors - pharmacology</subject><subject>human immunodeficiency virus</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Molecular Sequence Data</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkctrFEEQxgdR4ho9eRb65AOZtR_z2mMMaiIBF1wvXpqenmq31pnuTT9i9r_zT7M3uwQPglB0QX8_6qPqK4rnjM4Z5ezdZqKUVlRRJh4UM1ZzWlYdrR4WM0o5L3nDxePiSQibjAnGxUlx0lFRV7ybFb9Xaw9QDjiBDeisGsl1UjZiVBFvgITok47JQ6l0_sC4Ix7GrDkb1rglzpB1mpQlOE3JugEMagSrd-QGfQrk9eUbsvUuggpA0K6xx-h8mBM-J0sPA-o7m637BZ6kgPYHGXHCCAOB2-3o_J3V3kaNEbxVEUiPdtiDU7YLT4tHRo0Bnh37afHt44fV-UV59eXT5fnZVakEpbFkRlea5-pET5u2yfeqTNNw1fa9oFpDr40ZTA2syk8D2lSg204b0anFoHtxWrw8zM3bXCcIUU4YNIyjsuBSkG1TL0TVif-CrGnbBadNBt8eQO1dCB6M3HqclN9JRuU-WPlXsJl-cRyb-gmGe_aYZNbLg44hwu29rPxP2bSireVq-VW-p995ffF5KVeZf3XglQ5y41I-7Rj-6fwHCt3AWg</recordid><startdate>19940701</startdate><enddate>19940701</enddate><creator>Oprea, Tudor I</creator><creator>Waller, Chris L</creator><creator>Marshall, Garland R</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19940701</creationdate><title>Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes</title><author>Oprea, Tudor I ; Waller, Chris L ; Marshall, Garland R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a300t-1fc4c24c283b06760404f662a7bb30ccebcffdf5e14f5e6ecf4ec78cf38a9dcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>AIDS/HIV</topic><topic>Amino Acid Sequence</topic><topic>Binding Sites</topic><topic>HIV Protease</topic><topic>HIV Protease Inhibitors - chemistry</topic><topic>HIV Protease Inhibitors - pharmacology</topic><topic>human immunodeficiency virus</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Molecular Sequence Data</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oprea, Tudor I</creatorcontrib><creatorcontrib>Waller, Chris L</creatorcontrib><creatorcontrib>Marshall, Garland R</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oprea, Tudor I</au><au>Waller, Chris L</au><au>Marshall, Garland R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1994-07-01</date><risdate>1994</risdate><volume>37</volume><issue>14</issue><spage>2206</spage><epage>2215</epage><pages>2206-2215</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>NewPred, a semiautomated procedure to evaluate alternate binding modes and assist three dimensional quantitative structure-activity relationship (3D-QSAR) studies in predictive power evaluation is exemplified with a series of 30 human immunodeficiency virus 1 protease (HIV PR) inhibitors. Five comparative molecular field analysis (CoMFA) models (Waller, C. L.; et al. J. Med. Chem. 1993, 36, 4152-4160) based on 59 HIV-PR inhibitors were tested. The test set included 18 compounds (set A) having a different transition state isostere (TSI), hydroxyethylurea (Getman, D. P.; et al. J. Med. Chem. 1993, 36, 288-291), to investigate the binding mode in P1' and P2'. Twelve dihyroxyethylenes (set B) (Thaisrivongs, S.; et al. J. Med. Chem. 1993, 36, 941-952) were used to investigate binding in P2 and P3 as well as in P2' and P3'. Six other compounds with known or inferred binding structure (set C) were part of the test set, but not investigated with NewPred. Each compound was aligned in accordance to predefined alignment rules for the training set prior to the inclusion in the test set (except for set C). Using NewPred, geometrically different conformers for each compound were generated and individually relaxed in the HIV-PR binding site. Energy comparisons allowed selection of lowest energy structures to be included in the test set. Only in vacuo minimized conformers derived from low-energy complexes were used to determine the predictive power of the five models (predictive r2 varied from 0.1 to 0.7 when two chemical and statistical outliers were excluded). Our models correctly predict the poor inhibitor activity of 1(S)-amino-2(R)-hydroxyindan-containing peptides (set B), which is explained and interpreted from a 3D-QSAR perspective. The use of a new, flexibility-based, semiautomated method to explore alternate binding models for 3D-QSAR models is demonstrated.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>8035428</pmid><doi>10.1021/jm00040a013</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1994-07, Vol.37 (14), p.2206-2215
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_76593483
source MEDLINE; ACS Publications
subjects AIDS/HIV
Amino Acid Sequence
Binding Sites
HIV Protease
HIV Protease Inhibitors - chemistry
HIV Protease Inhibitors - pharmacology
human immunodeficiency virus
Models, Molecular
Molecular Conformation
Molecular Sequence Data
Structure-Activity Relationship
title Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T03%3A38%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Three-dimensional%20quantitative%20structure-activity%20relationship%20of%20human%20immunodeficiency%20virus%20(I)%20protease%20inhibitors.%202.%20Predictive%20power%20using%20limited%20exploration%20of%20alternate%20binding%20modes&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Oprea,%20Tudor%20I&rft.date=1994-07-01&rft.volume=37&rft.issue=14&rft.spage=2206&rft.epage=2215&rft.pages=2206-2215&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/jm00040a013&rft_dat=%3Cproquest_cross%3E76593483%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16779206&rft_id=info:pmid/8035428&rfr_iscdi=true